Zelmic will participate at CPHI Frankfurt on November 1-3, 2022 David Sagna is excited to meet new clients and suppliers to discuss topical drug development and the opportunities with the new IMP topical manufacturing unit. This trip was facilitated in connection with the EU.
Zelmic will attend The Future of Swedish and Danish Life Science on the 2nd of September. David Sagna, CEO, and Ph.D. Susanne Nilsson, Head of Development will be present at the event.